Error in Figure/Table
In the original publication [1], there was a mistake in Figures 3 and 5, as well as Table 1, when published. There was a typo in the unit. The corrected Figure 3 and Figure 5, as well as Table 1, appear below.
Figure 3.
Food and fluid intake, body weight, and blood glucose changes over four weeks in both control and experimental groups of rats. a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05, C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Figure 5.
Glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD) in control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9). a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05. GSH-Px: Glutathione peroxidase; SOD: superoxide dismutase; C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Table 1.
Malondialdehyde (MDA) control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9).
Error in Text
There was also an error in the Section 2.6, Preparation of Samples and Biochemical Testing, the second sentence of the second paragraph. The kit brand used was spelled incorrectly.
The original version stated the following:
The levels of insulin, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) were measured in the plasma, heart, skeletal muscle, liver, and kidney using ELISA kits from Sunlong Biotech, Zhejiang, China.
The corrected version of the kits’ brand name stated as follows:
The levels of insulin, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) were measured in the plasma, heart, skeletal muscle, liver, and kidney using ELISA kits from YL Biont (Shanghai, China).
The author states that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).